BMI OrganBank is advancing toward clinical trial with FDA Breakthrough Device Designation, strong preclinical data, and an active fundraising round. If you're interested in learning more about investment opportunities, we'd like to connect.
Proprietary acellular perfusate designed to support metabolically active preservation—enabling oxygen delivery, nutrient support, and management of oxidative stress without the need for donor-matched blood.
Real-time visibility across the journey
Tracks organ status and location during preservation and transport, supporting coordination and assessment across teams.
Portable perfusion. Continuous preservation.
Automated, portable device designed to maintain kidneys in a metabolically active state during preservation and transport.
Operates at room temperature without donor-matched blood.
